This Climate Report Is Huge for Renewable Energy
The UN Climate Change Conference gets plenty of media coverage.
World leaders gathering and making climate pledges is certainly a noteworthy event.
But there was another noteworthy event that took place last week. And it didn’t receive as much attention.
The Intergovernmental Panel on Climate Change (IPCC) released part of its latest report.
The IPCC gathers the scientific, economic and governmental consensus from 195 member countries.
These reports are more important than most people realize.
For smaller countries that can’t study climate change independently, they provide a blueprint.
They’re also the source of the information that’s later discussed at climate conferences.
The last one came out eight years ago and was the main source of scientific input to the Paris Agreement.
So what does the latest report say?
So Far, Government Efforts Are Lacking
Let’s start with the bad news first.
Since the Paris Agreement in 2015, the goal has been to limit global temperature rise to 1.5 degrees Celsius in this century.
The latest IPCC report shows that the window to make changes to meet this goal is rapidly closing.
The chances of ramping up efforts seem difficult due to the lack of political will around the world.
Only 24 countries are currently reducing emissions.
And the wealthiest of these 24 countries are doing the bare minimum when they could be doing more.
To make matters worse, it’s not enough that the world transitions to cleaner energy sources.
The IPCC also recommends investing in methods of removing carbon from the atmosphere.
This includes planting more trees and developing carbon storage technology.
In other words, the path to meet the 1.5 degree target won’t be easy.
Renewables Are Now Cheaper Than Fossil Fuels
Now, on to the good news.
The charts below from the IPCC show the same story with different types of clean energy.
The cost of renewables plunged over the last decade.
Renewable Energy Is Much Cheaper Than It Was 10 Years Ago
Renewables are now cheaper than or competitive with fossil fuels.
They’re now the cheaper choice for most individuals and businesses.
And as their costs drop, the adoption rate skyrockets.
Renewable Energy Adoption Is Surging Around the World
These forms of energy still have plenty of room to grow.
They collectively make up less than a third of the global energy mix.
As for governments, the last IPCC report sparked the Paris Agreement.
I expect this one will spark more commitments at the next climate conference.
Besides, governments are already calling into question their reliance on countries like Russia for fossil fuels.
Together, this sets the stage for great opportunities in the renewables space.
You can check out Ian King’s Strategic Fortunes service for investment ideas on renewables.
It covers everything from solar power to battery technology.
Research Analyst, Strategic Fortunes
From open till noon Eastern time.
Antares Pharma Inc. (Nasdaq: ATRS) develops, manufactures and commercializes novel therapeutic products using advanced drug delivery systems. The stock jumped 49% after Halozyme Therapeutics struck a deal to buy out the company for $960 million.
Sierra Oncology Inc. (Nasdaq: SRRA) develops and commercializes therapies for the treatment of patients with hematology and oncology needs. The stock is up 39% on the news that it is set to be acquired by GlaxoSmithKline for $1.9 billion.
HighPeak Energy Inc. (Nasdaq: HPK) engages in the acquisition, exploration, development and production of oil and natural gas. It is up 30% on positive attention from CNCB’s Mad Money host Jim Cramer, who dedicated a segment to the stock.
Turning Point Therapeutics Inc. (Nasdaq: TPTX) designs and develops therapies that target genetic drivers of cancer. The stock is up 25% after the company announced positive topline data from a study of its drug candidate Repotrectinib on advanced non-small-cell lung cancer.
Exscientia plc (Nasdaq: EXAI) is an artificial intelligence-driven pharmatech company that discovers, designs and develops drugs. It is up 20% after analysts at Morgan Stanley maintained its hold rating on the stock and raised the price target on it.
Crinetics Pharmaceuticals Inc. (Nasdaq: CRNX) focuses on the discovery and development of therapeutics for rare endocrine diseases and endocrine-related tumors. It is up 17% after announcing the pricing on its new equity offering to raise $125 million to help fund research and development.
Veru Inc. (Nasdaq: VERU) focuses primarily on developing medicines for the management of cancers. The stock is up 16%, continuing its run from earlier in the week when results from its Phase 3 trial of its oral COVID-19 treatment showed a meaningful reduction in deaths.
AVZ Minerals Ltd. (OTC: AZZVF) explores and mines for lithium, tin, tantalum and cesium deposits. It is up 16% after the company received a positive technical opinion on its Manono Lithium Project from Congo’s Department of Mines, putting it closer to securing a mining license.
Aterian Inc. (Nasdaq: ATER) offers a software technology platform that uses machine learning, natural language processing and data analytics to design, develop, market and sell products. It has no significant news to report; rather, it is up 15% on high levels of interest in the stock on social media.
Stronghold Digital Mining Inc. (Nasdaq: SDIG) is a crypto asset mining company that focuses mainly on mining bitcoin. It is up 10% thanks to the uptrend in the crypto markets today.